These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25166031)

  • 1. Targets in osteoporosis treatment.
    Bandeira F; Paula FJ; Lazaretti-Castro M; Premaor MO
    Arq Bras Endocrinol Metabol; 2014 Jul; 58(5):409-10. PubMed ID: 25166031
    [No Abstract]   [Full Text] [Related]  

  • 2. Bisphosphonates for osteoporosis--where do we go from here?
    Whitaker M; Guo J; Kehoe T; Benson G
    N Engl J Med; 2012 May; 366(22):2048-51. PubMed ID: 22571168
    [No Abstract]   [Full Text] [Related]  

  • 3. Bisphosphonates may help men with osteoporosis.
    Harv Health Lett; 2013 Jan; 38(3):8. PubMed ID: 23556169
    [No Abstract]   [Full Text] [Related]  

  • 4. Vitamin D receptor genotypes and response to zoledronic acid therapy in thalassemia-induced osteoporosis.
    Otrock ZK; Mahfouz RA; Charafeddine KM; Rayes RF; Zahed LF; Taher AT
    Ann Hematol; 2008 Nov; 87(11):947-8. PubMed ID: 18443790
    [No Abstract]   [Full Text] [Related]  

  • 5. How to prevent glucocorticoid-induced osteoporosis.
    Dore RK
    Cleve Clin J Med; 2010 Aug; 77(8):529-36. PubMed ID: 20682515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [When should bisphosphonate treatment be discontinued?].
    Eriksen EF; Halse J
    Tidsskr Nor Laegeforen; 2012 Aug; 132(14):1630-2. PubMed ID: 22875131
    [No Abstract]   [Full Text] [Related]  

  • 7. Continuous increase in erythropoietic activity despite the improvement in bone mineral density by zoledronic acid in patients with thalassemia intermedia-induced osteoporosis.
    Voskaridou E; Christoulas D; Antoniadou L; Terpos E
    Acta Haematol; 2008; 119(1):40-4. PubMed ID: 18253025
    [No Abstract]   [Full Text] [Related]  

  • 8. [Up-to-date treatments for osteoporosis].
    Bors K
    Orv Hetil; 2006 Feb; 147(7):301-6. PubMed ID: 17489157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Osteoporosis in patients under treatment for cancer and the possibilities for prevention and treatment].
    Eekhoff EM; Pinedo HM; Lips P
    Ned Tijdschr Geneeskd; 2007 Jun; 151(25):1388-93. PubMed ID: 17668601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis and treatment of osteoporosis in men].
    Hosoi T
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():495-8. PubMed ID: 18161155
    [No Abstract]   [Full Text] [Related]  

  • 11. [Vitamin K2 treatment for osteoporosis: what is the evidence today?].
    Ishida Y
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():409-14. PubMed ID: 18161141
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug therapy for osteoporosis patients with low back pain].
    Yamazaki K
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():577-80. PubMed ID: 18161169
    [No Abstract]   [Full Text] [Related]  

  • 13. New approaches to the treatment of osteoporosis.
    Silva BC; Bilezikian JP
    Annu Rev Med; 2011; 62():307-22. PubMed ID: 21054170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New bone density conservation agents for osteoporosis under research and development: Zoledronate].
    Wada S; Fukawa T; Kamiya S
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():421-5. PubMed ID: 18161143
    [No Abstract]   [Full Text] [Related]  

  • 15. Male osteoporosis.
    Ducharme N
    Clin Geriatr Med; 2010 May; 26(2):301-9. PubMed ID: 20497848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Image assessment of the treatment effect on osteoporosis: bisphosphonates].
    Sone T
    Clin Calcium; 2011 Jul; 21(7):1041-6. PubMed ID: 21719985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoporosis in men.
    Joy M
    N Engl J Med; 2008 Aug; 359(8):868; author reply 869. PubMed ID: 18724403
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening for osteoporosis.
    Croswell J
    Am Fam Physician; 2011 May; 83(10):1201-2. PubMed ID: 21568255
    [No Abstract]   [Full Text] [Related]  

  • 19. [First choice drug for treatment of osteoporosis and the strategic points for choice of drugs].
    Soen S
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():325-8. PubMed ID: 18159713
    [No Abstract]   [Full Text] [Related]  

  • 20. [Osteoporosis--new therapeutic possibilities. The Danish Bone Society].
    Langdahl BL; Rejnmark L;
    Ugeskr Laeger; 2008 Mar; 170(12):1043. PubMed ID: 18397661
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.